Marizyme Inc (MRZM)
0.072
-0.02
(-24.21%)
USD |
OTCM |
May 03, 16:00
Marizyme Profit Margin (Quarterly): -17.88K% for Sept. 30, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | -17.88K% |
| June 30, 2023 | -11.14K% |
| March 31, 2023 | -1.98K% |
| December 31, 2022 | -24.63K% |
| September 30, 2022 | -2.04K% |
| June 30, 2022 | -11.20K% |
| March 31, 2022 | |
| December 31, 2021 | |
| September 30, 2021 | -4.39K% |
| June 30, 2021 | -1.02K% |
| March 31, 2021 | -3.80K% |
| December 31, 2020 | -3.98K% |
| September 30, 2020 | -1.65K% |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 | -13.43K% |
| June 30, 2018 | -385.5% |
| March 31, 2018 | -863.9% |
| December 31, 2017 | -2.18K% |
| September 30, 2017 | 96.13% |
| Date | Value |
|---|---|
| December 31, 2013 | -1.55% |
| September 30, 2013 | -22.46% |
| June 30, 2013 | -3.75% |
| March 31, 2013 | -25.54% |
| December 31, 2012 | -4.24% |
| September 30, 2012 | -6.85% |
| June 30, 2012 | -11.46% |
| March 31, 2012 | -94.92% |
| December 31, 2011 | -11.01% |
| September 30, 2011 | -25.53% |
| June 30, 2011 | -31.97% |
| March 31, 2011 | -16.79% |
| December 31, 2010 | -0.99% |
| September 30, 2010 | -13.32% |
| June 30, 2010 | 6.56% |
| March 31, 2010 | 2.29% |
| December 31, 2009 | |
| September 30, 2009 | |
| June 30, 2009 | -145.0% |
| March 31, 2009 | 90.19% |
| December 31, 2008 | -122.5% |
| September 30, 2008 | -448.7% |
| June 30, 2008 | -976.7% |
| March 31, 2008 | -302.9% |
| December 31, 2007 | -317.8% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-24.63K%
Minimum
Dec 2022
-1.02K%
Maximum
Jun 2021
-7.61K%
Average
-3.98K%
Median
Dec 2020
Profit Margin (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -110.2% |
| Palatin Technologies Inc | -385.6% |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -671.6% |
| Return on Assets | -184.4% |
| Return on Invested Capital | -378.5% |
| Gross Profit Margin (Quarterly) | 71.91% |
| Operating Margin (Quarterly) | -2.68K% |
| Return on Net Operating Assets | -185.6% |